Publication
Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study.
Hiroshi Yokouchi, Hiroshi Nishihara, Yoshiyuki Kenmotsu, Kosuke Tsuji, Takayuki Kishikawa, Hajime Kikuchi, Eisaku Miyauchi, Yutaro Nagano, Kenya Kanazawa, Jun Sugisaka, Takayuki Ohkuri, Satoshi Oizumi
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260908-000002
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Nivolumab is used as a second-line treatment for pleural mesothelioma (PM); however, predictive or prognostic biomarkers remain unclear. We aimed to identify factors associated with survival in nivolumab-treated PM patients. METHODS: This retrospective, multi-institutional cohort study…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Mesotheliomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available